Tech Company Financing Transactions
HTG Molecular Diagnostics Funding Round
SR One Capital Management participated in a $16.2 million Series D venture round for HTG Molecular Diagnostics. The funding round was recorded on 6/13/2011.
Transaction Overview
Company Name
Announced On
6/13/2011
Transaction Type
Venture Equity
Amount
$16,200,000
Round
Series D
Investors
SR One Capital Management (Simeon George)
Proceeds Purpose
The new financing will be used to fuel the growth and adoption of HTG's multi-plex gene expression testing platform in three key business areas: molecular testing capabilities for translational medicine, pharmaceutical clinical development and pathology laboratory diagnostics. The company is actively hiring personnel with specific experience working in diagnostics in the following areas: sales and marketing, scientific R&D and operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3430 East Global Loop
Tucson, AZ 85706
USA
Tucson, AZ 85706
USA
Phone
Website
Email Address
Overview
Headquartered in Tucson, Arizona, HTG Molecular Diagnostics' mission is to empower precision medicine at the local level.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Timothy Johnson
Chief Executive Officer
John Lubniewski
VP - Finance
Shaun McMeans
VP - Regulatory Affairs
Sam Rua
Browse more venture capital transactions:
Prev: 6/13/2011: AisleBuyer venture capital transaction
Next: 6/13/2011: Agrivida venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs